Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodeoxycholic acid plus mesalazine for ulcerative colitis
ChiCTR2000038316Phase 4Completed
- Sponsor
- 900th Hospital of the Joint Logistics Force, People's Liberation Army
- Start
- Aug 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ursodeoxycholic acid in autoimmune colitis and reflux gastritis (4 arms), sponsored by 900th Hospital of the Joint Logistics Force, People's Liberation Army. Primary endpoint: Intestinal flora composition. Started Aug 2017; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
autoimmune colitisreflux gastritis
Beyond the preview
Go deeper on ChiCTR2000038316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038316.